ATE366128T1 - Pharmazeutische zusammensetzung - Google Patents

Pharmazeutische zusammensetzung

Info

Publication number: ATE366128T1
Authority: AT; Austria
Prior art keywords: pharmaceutical composition; pharmaceutical; composition
Prior art date: 2000-09-11

Application number

AT01982270T

Other languages

English (en)

Inventor

Simon Bateman

Alberto Gimona

Jurij Holinej

Jasper Huels

Sumedha Jayawardene

Argeris Karabelas

Maha Khaled

Anees Karnachi

Lochlainn Eimear Nic

Richard Macerata

Victor Sloan

Original Assignee

Novartis Pharma Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-09-11

Filing date

2001-09-10

Publication date

2007-07-15

2001-09-10 Application filed by Novartis Pharma Gmbh filed Critical Novartis Pharma Gmbh

2007-07-15 Application granted granted Critical

2007-07-15 Publication of ATE366128T1 publication Critical patent/ATE366128T1/de

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Rheumatology (AREA)
Immunology (AREA)
Pain & Pain Management (AREA)
Endocrinology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Diabetes (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AT01982270T 2000-09-11 2001-09-10 Pharmazeutische zusammensetzung ATE366128T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US23165500P	2000-09-11	2000-09-11
US23226100P	2000-09-14	2000-09-14

Publications (1)

Publication Number	Publication Date
ATE366128T1 true ATE366128T1 (de)	2007-07-15

Family

ID=26925315

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT01982270T ATE366128T1 (de)	2000-09-11	2001-09-10	Pharmazeutische zusammensetzung

Country Status (28)

Country	Link
US (2)	US20020061932A1 (de)
EP (1)	EP1331972B1 (de)
JP (2)	JP2004527458A (de)
KR (1)	KR20030036730A (de)
CN (1)	CN100490797C (de)
AR (1)	AR030630A1 (de)
AT (1)	ATE366128T1 (de)
AU (2)	AU2002213900C1 (de)
BR (1)	BR0113809A (de)
CA (1)	CA2416771C (de)
CY (1)	CY1107729T1 (de)
CZ (1)	CZ2003673A3 (de)
DE (1)	DE60129238T2 (de)
DK (1)	DK1331972T3 (de)
ES (1)	ES2290181T3 (de)
HU (1)	HUP0301128A3 (de)
IL (2)	IL154238A0 (de)
MX (1)	MXPA03002105A (de)
MY (1)	MY126117A (de)
NO (1)	NO20031095L (de)
NZ (1)	NZ524785A (de)
PE (1)	PE20020351A1 (de)
PL (1)	PL359721A1 (de)
PT (1)	PT1331972E (de)
RU (1)	RU2316324C2 (de)
SI (1)	SI1331972T1 (de)
SK (1)	SK2902003A3 (de)
WO (1)	WO2002020090A2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PE20030323A1 (es) *	2001-08-31	2003-05-12	Novartis Ag	Composicion farmaceutica
GB0201520D0 (en) *	2002-01-23	2002-03-13	Novartis Ag	Pharmaceutical uses
RU2318497C2 (ru) *	2002-03-07	2008-03-10	Новартис Аг	Фармацевтические композиции
US7220749B2 (en)	2002-06-11	2007-05-22	Nitromed, Inc.	Nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use
AR042206A1 (es)	2002-11-26	2005-06-15	Novartis Ag	Acidos fenilaceticos y derivados
TWI327913B (en) *	2003-03-12	2010-08-01	Novartis Ag	Pharmaceutical composition comprising 5-methyl-2-(2'-chloro-6'-fluoroanilino)phenylacetic acid
US20050131028A1 (en) *	2003-09-11	2005-06-16	Pharmacia Corporation	Methods and compositions for the extended duration treatment of pain, inflammation and inflammation-related disorders
RU2423979C2 (ru) *	2005-06-17	2011-07-20	АФТ Фармасьютикалз Лимитед	Новая фармацевтическая композиция и ее применение в способе лечения пациентов с гиперемией и отеком слизистой оболочки верхних дыхательных путей
FR2898492B1 (fr) *	2006-03-15	2008-06-06	Pierre Fabre Medicament Sa	Comprimes orodispersibles de domperidone
EP2043613A1 (de) *	2006-07-14	2009-04-08	Fmc Corporation	Feste form
WO2008086530A2 (en) *	2007-01-11	2008-07-17	Analog Devices, Inc.	Mems sensor with cap electrode
WO2010022211A1 (en) *	2008-08-22	2010-02-25	Novartis Ag	Use of a cox-2 inhibitor for the treatment of a cox-2 dependent disorder in a patient not carrying hla alleles associated with hepatotoxicity
WO2010056741A2 (en)	2008-11-12	2010-05-20	Auspex Pharmaceuticals, Inc.	Phenylacetic acid inhibitors of cyclooxygenase
CN103773596B (zh) *	2013-12-31	2016-05-18	上海复力生物医药科技有限公司	磷虾油的制备方法
WO2018049027A1 (en)	2016-09-07	2018-03-15	Trustees Of Tufts College	Combination therapies using immuno-dash inhibitors and pge2 antagonists
CN111278433A (zh)	2017-09-26	2020-06-12	特沙诺有限公司	尼拉帕尼制剂

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ267417A (en) *	1993-06-08	1997-02-24	Ciba Geigy Ag	An inclusion compound of diclofenac and gamma-cyclodextrin and compressed dosage forms thereof
US5474995A (en) *	1993-06-24	1995-12-12	Merck Frosst Canada, Inc.	Phenyl heterocycles as cox-2 inhibitors
AU3004997A (en) *	1996-05-17	1997-12-09	Merck & Co., Inc.	Compositions for a once a day treatment of cyclooxygenase-2 mediated diseases
CO4960662A1 (es) *	1997-08-28	2000-09-25	Novartis Ag	Ciertos acidos 5-alquil-2-arilaminofenilaceticos y sus derivados
SA99191255B1 (ar) *	1998-11-30	2006-11-25	جي دي سيرل اند كو	مركبات سيليكوكسيب celecoxib
PE20030323A1 (es) *	2001-08-31	2003-05-12	Novartis Ag	Composicion farmaceutica

2001
- 2001-09-07 AR ARP010104260A patent/AR030630A1/es unknown
- 2001-09-07 PE PE2001000900A patent/PE20020351A1/es not_active Application Discontinuation
- 2001-09-10 MY MYPI20014237A patent/MY126117A/en unknown
- 2001-09-10 CZ CZ2003673A patent/CZ2003673A3/cs unknown
- 2001-09-10 AT AT01982270T patent/ATE366128T1/de active
- 2001-09-10 RU RU2003109606/15A patent/RU2316324C2/ru not_active IP Right Cessation
- 2001-09-10 HU HU0301128A patent/HUP0301128A3/hu unknown
- 2001-09-10 WO PCT/EP2001/010448 patent/WO2002020090A2/en not_active Ceased
- 2001-09-10 PT PT01982270T patent/PT1331972E/pt unknown
- 2001-09-10 ES ES01982270T patent/ES2290181T3/es not_active Expired - Lifetime
- 2001-09-10 PL PL35972101A patent/PL359721A1/xx not_active Application Discontinuation
- 2001-09-10 MX MXPA03002105A patent/MXPA03002105A/es active IP Right Grant
- 2001-09-10 NZ NZ524785A patent/NZ524785A/en unknown
- 2001-09-10 IL IL15423801A patent/IL154238A0/xx active IP Right Grant
- 2001-09-10 SI SI200130773T patent/SI1331972T1/sl unknown
- 2001-09-10 KR KR10-2003-7002711A patent/KR20030036730A/ko not_active Ceased
- 2001-09-10 JP JP2002524572A patent/JP2004527458A/ja not_active Withdrawn
- 2001-09-10 DE DE60129238T patent/DE60129238T2/de not_active Expired - Lifetime
- 2001-09-10 EP EP01982270A patent/EP1331972B1/de not_active Expired - Lifetime
- 2001-09-10 AU AU2002213900A patent/AU2002213900C1/en not_active Ceased
- 2001-09-10 CN CNB018154549A patent/CN100490797C/zh not_active Expired - Fee Related
- 2001-09-10 SK SK290-2003A patent/SK2902003A3/sk unknown
- 2001-09-10 BR BR0113809-0A patent/BR0113809A/pt not_active Application Discontinuation
- 2001-09-10 DK DK01982270T patent/DK1331972T3/da active
- 2001-09-10 AU AU1390002A patent/AU1390002A/xx active Pending
- 2001-09-10 CA CA2416771A patent/CA2416771C/en not_active Expired - Fee Related
- 2001-09-11 US US09/950,538 patent/US20020061932A1/en not_active Abandoned
2003
- 2003-01-30 IL IL154238A patent/IL154238A/en not_active IP Right Cessation
- 2003-03-10 NO NO20031095A patent/NO20031095L/no not_active Application Discontinuation
2004
- 2004-03-24 US US10/807,734 patent/US20040186179A1/en not_active Abandoned
2007
- 2007-09-07 CY CY20071101157T patent/CY1107729T1/el unknown
2011
- 2011-03-09 JP JP2011051754A patent/JP2011144194A/ja active Pending

Also Published As

Publication number	Publication date
DE60129238T2 (de)	2008-03-06
ES2290181T3 (es)	2008-02-16
EP1331972B1 (de)	2007-07-04
MXPA03002105A (es)	2003-06-19
WO2002020090A3 (en)	2003-05-30
KR20030036730A (ko)	2003-05-09
MY126117A (en)	2006-09-29
NO20031095D0 (no)	2003-03-10
RU2316324C2 (ru)	2008-02-10
WO2002020090A2 (en)	2002-03-14
CA2416771A1 (en)	2002-03-14
EP1331972A2 (de)	2003-08-06
AU2002213900B2 (en)	2006-02-16
US20020061932A1 (en)	2002-05-23
CN100490797C (zh)	2009-05-27
BR0113809A (pt)	2003-07-29
CN1455691A (zh)	2003-11-12
DK1331972T3 (da)	2007-11-05
AU2002213900C1 (en)	2006-07-27
CY1107729T1 (el)	2013-04-18
JP2004527458A (ja)	2004-09-09
AU1390002A (en)	2002-03-22
HUP0301128A2 (hu)	2003-10-28
WO2002020090A9 (en)	2003-10-30
US20040186179A1 (en)	2004-09-23
CZ2003673A3 (cs)	2003-06-18
DE60129238D1 (de)	2007-08-16
HUP0301128A3 (en)	2005-04-28
CA2416771C (en)	2010-11-02
PE20020351A1 (es)	2002-06-14
PT1331972E (pt)	2007-10-16
NO20031095L (no)	2003-03-10
NZ524785A (en)	2005-10-28
AR030630A1 (es)	2003-08-27
SI1331972T1 (sl)	2007-12-31
PL359721A1 (en)	2004-09-06
IL154238A0 (en)	2003-09-17
IL154238A (en)	2008-11-26
JP2011144194A (ja)	2011-07-28
SK2902003A3 (en)	2003-10-07

Legal Events

Date

Code

Title

Description

2007-11-15

UEP

Publication of translation of european patent specification

Ref document number: 1331972

Country of ref document: EP

Publication	Publication Date	Title
ATE468324T1 (de)	2010-06-15	Pharmazeutische zusammensetzung
ATE279961T1 (de)	2004-11-15	Neue pharmazeutische zusammensetzung
AT7729U3 (de)	2006-01-15	Pharmazeutische zusammensetzungen enthaltend amlodipinmaleat
ITTO20010008A0 (it)	2001-01-10	Formulazione farmaceutica
AR028204A1 (es)	2003-04-30	Composiciones farmaceuticas electrohiladas
FI20105657L (fi)	2010-06-10	Farmaseuttisia koostumuksia
ITMI20010748A0 (it)	2001-04-06	Composizioni farmaceutiche
ATE404180T1 (de)	2008-08-15	Geschmacksmaskierte pharmazeutische partikel
NO20025450L (no)	2002-11-14	Ny farmasöytisk sammensetning
NO20015175L (no)	2001-10-23	Farmasöytisk sammensetning
ATE331529T1 (de)	2006-07-15	Antigen enthaltende pharmazeutische zusammensetzung
FI991485L (fi)	2000-12-31	Uusi farmaseuttinen koostumus
FI20011478A0 (fi)	2001-07-05	Farmaseuttinen koostumus
NO20030627D0 (no)	2003-02-07	Hydrogel-drevet medikament doseringsform
ATE334656T1 (de)	2006-08-15	Flüssige pharmazeutische zusammensetzung
ATE307571T1 (de)	2005-11-15	Pharmazeutische formulierung enthaltend bicalutamid
EE05020B1 (et)	2008-06-16	Glburiidi ravimkoostis
NO20026123L (no)	2003-02-18	Farmasöytiske sammensetninger
DE60129238D1 (de)	2007-08-16	Pharmazeutische zusammensetzung
FI20022128A0 (fi)	2002-12-03	Farmaseuttinen koostumus
ATE324883T1 (de)	2006-06-15	Pharmazeutische zusammensetzung enthaltend lumiracoxib
DE60217390D1 (de)	2007-02-15	Bicalutamid enthaltende pharmazeutische zusammensetzung
FI4488U1 (fi)	2000-07-20	Farmaseuttinen koostumus
EP1124557A4 (de)	2002-08-07	Pharmazeutische zusammensetzung
DE10291905D2 (de)	2004-05-27	Pharmazeutische Zusammensetzung